ABOUT US
ABOUT US
Accelerating drug development with synthetic biology and next-generation sequencing
We are a team of synthetic biologists, next-generation sequencing experts, and computational biologists focused on discovering better drugs faster.
Central to our vision is AlphaSeq, the leading technology for quantitative and multiplexed measurements of protein-protein interactions.
A-Alpha Bio was founded in 2017 as a spinout from the University of Washington's Institute for Protein Design and Center for Synthetic Biology.
ABOUT A-ALPHA BIO
Management Team
David co-invented AlphaSeq while working on his PhD in Bioengineering at the University of Washington with scientific advisors David Baker and Eric Klavins. He is an expert in developing and optimizing high-impact technologies by combining molecular biology, genetic engineering, and next-generation sequencing.
Randolph received his PhD in Bioengineering from the University of Washington. Before UW, he was a Process Development Engineer at Illumina, where he was responsible for improving quality control efficiency and translating products into manufacturing. Since then, he has expanded his expertise into synthetic biology and computer science.
Ryan earned his PhD in Genome Sciences at the University of Washington before starting at Adaptive Biotechnologies. At Adaptive, he built and led the Antigen Map Project, in which Adaptive and Microsoft set out to jointly learn how to “read” the immune system for disease diagnosis. He is now using his expertise in sequencing, proteomics, and computational analysis to build and optimize A-Alpha Bio's data science pipeline.
Advisors
Dr. Eric Klavins, PhD
SCIENTIFIC ADVISOR
Professor, UW Electrical Engineering
Director, UW Center for Synthetic Biology
Director, UW BIOFAB
Dr. David Baker, PhD
SCIENTIFIC ADVISOR
Professor, UW Biochemistry & HHMI
Director, UW Institute for Protein Design
Member, NAS & AAS
Dr. Lance Stewart, PhD, MBA
STRATEGIC & SCIENTIFIC ADVISOR
CSOO, UW Institute for Protein Design
Co-founder, Beryllium Discovery & Northwest NeuroNeighborhood
Jade Brown, MBA
BUSINESS DEVELOPMENT ADVISOR
Former CBO at Cell Therapeutics
Former VP of BD at Xencor
Former Director at Eli Lilly
Dr. Chris Gibson, PhD
STRATEGIC & SCIENTIFIC ADVISOR
CEO and Co-Founder, Recursion Pharma